Non-Vitamin K Oral Anticoagulants Versus Warfarin for Patients With Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights
Cardiovascular Therapeutics - United Kingdom
doi 10.1111/1755-5922.12173
Full Text
Open PDFAbstract
Available in full text
Date
March 3, 2016
Authors
Publisher
Wiley